Browsing category

November 2022

Le U.S. Institute of Peace annonce que María Eugenia Mosquera Riascos est la lauréate du Women Building Peace Award 2022

WASHINGTON, 30 novembre 2022 /PRNewswire/ — Le U.S Institute of Peace (USIP) est fier d’annoncer que María Eugenia Mosquera Riascos, originaire de Colombie, a reçu le prix Women Building Peace Award 2022. « Le prix Women Building Peace Award rend hommage aux femmes qui font preuve d’un engagement, d’un leadership et d’un impact extraordinaires en faveur de la paix et de la résolution des […]

Read More

U.S. Institute of Peace Announces María Eugenia Mosquera Riascos as the 2022 Women Building Peace Award Recipient

WASHINGTON, Nov. 30, 2022 /PRNewswire/ — The U.S. Institute of Peace (USIP) is honored to announce María Eugenia Mosquera Riascos of Colombia as the recipient of the Institute’s 2022 Women Building Peace Award. “The Women Building Peace Award honors women of extraordinary commitment, leadership and impact who are working to build peace and resolve violent conflict […]

Read More

Conagen develops high-purity non-GMO sulforaphane by bioconversion

Commercial production is underway for 2023. Bedford, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) — Expanding on its portfolio of innovative nutritional products through biotechnology, Conagen, announced the development of its 99% high-purity sulforaphane. Made by a proprietary bioconversion technology, the company plans to begin the commercialization path in 2023. Conagen’s bioconversion methods enable the production […]

Read More

World Health Organization Updates Emergency Use Listing for Novavax Nuvaxovid COVID-19 Vaccine as a Primary Series in Adolescents and as a Booster in Adults

GAITHERSBURG, Md., Nov. 29, 2022 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the World Health Organization (WHO) has issued an updated Emergency Use Listing (EUL) for Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine for active immunization to prevent coronavirus disease 2019 (COVID-19) […]

Read More

Search

Search

Advertisement

Recent Posts

Advertisement